![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1441432
¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : Á¶»ç ¹× ¿¹Ãø - Á¦Ç°º°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº° ºÐ¼®(2023-2030³â)Global Wearable Medical Devices Market Size study & Forecast, by Product, by Application, by Distribution Channel and Regional Analysis, 2023-2030 |
¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀº 2022³â¿¡ ¾à 591¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø±â°£(2023³â-2030³â) µ¿¾È 28.6% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
¿þ¾î·¯ºí ÀÇ·á±â±â´Â °Ç°°ú ÇູÀÇ ´Ù¾çÇÑ Ãø¸éÀ» ¸ð´ÏÅ͸µ, °ü¸® ¹× °³¼±Çϱâ À§ÇØ ½Åü¿¡ ÀåÂøÇϵµ·Ï ¼³°èµÈ ÈÞ´ë¿ë ¹× ¼ÒÇü ±â¼úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡¿¡´Â ÀϹÝÀûÀ¸·Î ¼¾¼, µ¥ÀÌÅÍ Ã³¸® ±â´É ¹× ¹«¼± ¿¬°áÀÌ ³»ÀåµÇ¾î ÀÖÀ¸¸ç ½Ç½Ã°£ °Ç° Á¤º¸¸¦ ¼öÁý ¹× Àü¼ÛÇÕ´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â´Â ½É¹Ú¼ö, Ç÷¾Ð, »ê¼Ò ³óµµ µîÀÇ »ýü »çÀÎ ¸ð´ÏÅ͸µ, ½Åü Ȱµ¿ ¹× ¼ö¸é ÆÐÅÏ ÃßÀû, ´ç´¢º´ ¹× È£Èí±â Áúȯ°ú °°Àº ¸¸¼º Áúȯ °ü¸® µî ´Ù¾çÇÑ ¸ñÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ´Â ¹è°æ¿¡´Â ¸¸¼º ÁúȯÀÇ À¯º´·ü »ó½Â, ÀÏ¹Ý ÁÖ¹ÎÀÇ °Ç° ÀÇ½Ä Áõ°¡, ÇÇÆ®´Ï½º µ¿Çâ Áõ°¡ µîÀÇ ¿äÀÎÀÌ ÀÖ½À´Ï´Ù.
¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½ÂÀº ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇÏ´Â Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, È£Èí±â Áúȯ µîÀÇ ¸¸¼º ÁúȯÀº ¼¼°èÀûÀ¸·Î Á¡Á¡ ´õ È®»êµÇ°í ÀÖÀ¸¸ç °Ç° °ü¸® ½Ã½ºÅÛ¿¡ Å« ºÎ´ãÀ»ÁÖ°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â´Â ÀÌ·¯ÇÑ Áõ»óÀ» °ü¸®ÇÏ´Â °³Àο¡°Ô ¿¹¹æÀûÀ̰í Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. Ȱ·Â ¡ÈÄ, Ȱµ¿ ¼öÁØ ¹× ±âŸ °ü·Ã °Ç° ÁöÇ¥¿Í °°Àº ÀÌ·¯ÇÑ Àåºñ¿¡¼ Á¦°øµÇ´Â ½Ç½Ã°£ µ¥ÀÌÅÍ´Â ÀáÀçÀûÀÎ ÇÕº´ÁõÀÇ Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô Çϰí Àû½Ã °³ÀÔÀ» ÃËÁøÇÕ´Ï´Ù. ±¹Á¦´ç´¢º´¿¬ÇÕ(International Diabetes Federation)ÀÇ 'Diabetes Atlas Tenth Edition 2021'¿¡ µû¸£¸é 2021³â¿¡´Â ¼¼°è¿¡¼ ¾à 5¾ï 3,700¸¸¸íÀÇ ¼ºÀο¡°Ô ´ç´¢º´ÀÌ ¹ß°ßµÇ¾úÀ¸¸ç, 2030³â¿¡´Â 6¾ï 4,300¸¸¸í, 2045 ³â¿¡´Â 7¾ï 8,300¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. °Ô´Ù°¡ ¹Ì±¹ ½ÉÀ庴ÇÐȸ(The American College of Cardiology)ÀÇ º¸°í¿¡ µû¸£¸é, 2021³â¿¡´Â 695¸¸¸íÀ̾ú´ø ½ÉÇ÷°ü ÁúȯÀÇ Áø´ÜÀ» ¹ÞÀº ¹Ì±¹ÀÎÀº 2030³â¿¡´Â ¾à 2,900¸¸¸íÀÌ µÈ´Ù°í ÁÁ¾Æ. 2020³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î 2¾ï 4,410¸¸ ¸íÀÌ ÇãÇ÷¼º ½ÉÀå ÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½ÂÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½º¸¶Æ®Æù°ú Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°úÀÇ ÅëÇÕ, °í·ÉÈ Àα¸ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ º¸¾È°ú ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í Á¦ÇÑµÈ »óȯ Á¤Ã¥Àº 2023³âºÎÅÍ 2030³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.
¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå Á¶»ç¿¡¼ °í·ÁÇÑ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â 2022³â¿¡ ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼´Â ½ÉÇ÷°ü Àå¾Ö, ´ç´¢º´, ¾ÏÀÇ ÀÌȯÀ²ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ºó¹øÇÑ Åë¿øÀÇ Çʿ伺À» ÃÖ¼ÒÈÇÏ¸é¼ ÀϰüµÇ°í Áö¼ÓÀûÀ̰í Àå±â°£ÀÇ È¯ÀÚ ¸ð´ÏÅ͸µÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÏ´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¹× ÀçÅà ÄÉ¾î ±â±âÀÇ º¸±ÞÀº ¿¹Ãø ±â°£À» ÅëÇØ ½ÃÀå È®´ë¸¦ ´õ ¹Ð¾î ³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª ½ÃÀåÀº ¿þ¾î·¯ºí ÀÇ·á±â±âÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â Á¤ºÎÀÇ Áö¿øÃ¥, ³ëÀÎ Àα¸ Áõ°¡, ÇコÄɾî ÁöÃâ Áõ°¡, ±Þ¼ÓÇÑ ±â¼ú Áøº¸, ÀçÅà ÄÉ¾î ±â±â ¼ö¿ä Áõ°¡, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÇ Çʿ伺 µîÀÇ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù.
ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³âµ¿¾È ´Ù¾çÇÑ ºÎ¹®¿Í ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇÏ°í ¾ÕÀ¸·Î ¸î ³â°£ÀÇ °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡¿¡¼ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î½ÃÀåÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.
Global Wearable Medical Devices Market is valued at approximately USD 59.12 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 28.6% during the forecast period 2023-2030. A wearable medical device is a portable and compact technology designed to be worn on the body to monitor, manage, or improve various aspects of health and well-being. These devices typically incorporate sensors, data processing capabilities, and wireless connectivity to collect and transmit real-time health information. Wearable medical devices can serve a range of purposes, including monitoring vital signs such as heart rate, blood pressure, and oxygen levels, tracking physical activity and sleep patterns, and managing chronic conditions such as diabetes or respiratory disorders. The Wearable Medical Devices Market is expanding because of factors such as the rising prevalence of chronic disorders, rising health consciousness among the general population and growing fitness trends.
The rising prevalence of chronic diseases is a significant driving force behind the growth of the Wearable Medical Devices Market. Chronic conditions, such as diabetes, cardiovascular diseases, and respiratory disorders, are becoming increasingly prevalent worldwide, placing a substantial burden on healthcare systems. Wearable medical devices offer a proactive and continuous monitoring solution for individuals managing these conditions. The real-time data provided by these devices, including vital signs, activity levels, and other relevant health metrics, enable early detection of potential complications and facilitate timely intervention. According to the International Diabetes Federation, Diabetes Atlas Tenth Edition 2021, about 537 million adults worldwide were discovered to have diabetes in 2021, with estimates showing that figure would rise to 643 million by 2030 and 783 million by 2045. Moreover, The American College of Cardiology reports that by 2030, there would be around 29 million Americans with a diagnosis of cardiovascular disease, up from 6.95 million in the year 2021. In 2020, 244.1 million people worldwide were living with ischemic heart disease. Thus, the rising prevalence of chronic conditions is driving the market growth. In addition, integration with smartphones and cloud computing and the rising aging population are creating new opportunities for market growth. However, data security and privacy concerns and limited reimbursement policies stifle market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Wearable Medical Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. The increasing incidence of cardiovascular disorders, diabetes, and cancer in this region is expected to drive market growth. The widespread adoption of remote patient monitoring and home care devices, aimed at providing consistent, continuous, and prolonged patient monitoring while minimizing the need for frequent hospital visits, is anticipated to further boost market expansion throughout the forecast period. Asia Pacific is expected to grow significantly over the forecast period. The market in the region is being driven by factors such as supportive government initiatives promoting the use of wearable medical instruments, a rising elderly population, and escalating healthcare expenditures, rapid technological advancements, increasing demand for home care devices, and the necessity for continuous monitoring.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: